Ogkologos

4396 ΔΗΜΟΣΙΕΥΣΕΙΣ 0 ΣΧΟΛΙΑ

FDA Grants Regular Approval to Rucaparib for Metastatic Castration-Resistant Prostate Cancer

Ogkologos - 29 Ιανουαρίου, 2026

ESMO Clinical Practice Guideline Express Update on the management of epithelial...

Ogkologos - 28 Ιανουαρίου, 2026

FDA Approves Lisocabtagene Maraleucel for Relapsed or Refractory Marginal Zone Lymphoma

Ogkologos - 28 Ιανουαρίου, 2026

ESMO Clinical Practice Guideline Express Update on the adoption of physical...

Ogkologos - 27 Ιανουαρίου, 2026

Mortality Trends for Most Cancers Remain Favourable In the EU, Although...

Ogkologos - 27 Ιανουαρίου, 2026

Abemaciclib Improves PFS at Six Months Among Patients with High-Grade Meningiomas...

Ogkologos - 26 Ιανουαρίου, 2026

N-of-1 Tailored Combination Therapy Matched to the Molecular Alterations, Facilitated by...

Ogkologos - 23 Ιανουαρίου, 2026

FDA Grants Traditional Approval to Tarlatamab-dlle for Extensive Stage Small Cell...

Ogkologos - 22 Ιανουαρίου, 2026

European Parliament Adopts Its Position on the Critical Medicines Act, Strengthening...

Ogkologos - 22 Ιανουαρίου, 2026

ESMO Raises Key Issues on Cancer Prevention and Care at the...

Ogkologos - 21 Ιανουαρίου, 2026

1...272829...440 Σελίδα 28 από 440

MOST POPULAR

EMA Recommends Extension of Indications for Nivolumab

20 Οκτωβρίου, 2020

Mom Battling Breast Cancer And Daughter With Alopecia Pose Together To...

7 Νοεμβρίου, 2019

Significant PFS Benefit in Patients with HR-positive, HER2-negative MBC Who Switched...

26 Μαΐου, 2023

EMA Recommends Granting a Marketing Authorisation for Crisantaspase

7 Σεπτεμβρίου, 2023

Φόρτωση περισσοτέρων

FDA Grants Regular Approval to Rucaparib for Metastatic Castration-Resistant Prostate Cancer

ESMO Clinical Practice Guideline Express Update on the management of epithelial...

FDA Approves Lisocabtagene Maraleucel for Relapsed or Refractory Marginal Zone Lymphoma

ESMO Clinical Practice Guideline Express Update on the adoption of physical...

Mortality Trends for Most Cancers Remain Favourable In the EU, Although...

Abemaciclib Improves PFS at Six Months Among Patients with High-Grade Meningiomas...

N-of-1 Tailored Combination Therapy Matched to the Molecular Alterations, Facilitated by...

FDA Grants Traditional Approval to Tarlatamab-dlle for Extensive Stage Small Cell...

European Parliament Adopts Its Position on the Critical Medicines Act, Strengthening...

ESMO Raises Key Issues on Cancer Prevention and Care at the...

MOST POPULAR

EMA Recommends Extension of Indications for Nivolumab

Mom Battling Breast Cancer And Daughter With Alopecia Pose Together To...

Significant PFS Benefit in Patients with HR-positive, HER2-negative MBC Who Switched...

EMA Recommends Granting a Marketing Authorisation for Crisantaspase

HOT NEWS

FDA Approves Engineered Cell Therapy for Advanced Synovial Sarcoma

Ahead of ESMO Immuno-Oncology Congress 2025: topics at a glance

ESMO Award for Immuno-Oncology 2025 Recipient Announced

ESMO’s Special Consultative Status with United Nations Economic and Social Council...

ΔΗΜΟΦΙΛΕΊΣ ΘΈΣΕΙΣ

ΚΑΡΚΙΝΟΣ ΘΥΜΟΥ ΑΔΕΝΑ (ΘΥΜΩΜΑ)

ΣΤΑΤΙΣΤΙΚΑ

ΚΕΝΤΡΙΚΟΥ ΝΕΥΡΙΚΟΥ ΣΥΣΤΗΜΑΤΟΣ

ΔΗΜΟΦΙΛΗ ΚΑΤΗΓΟΡΙΑ